Skip to main content
Amplia Therapeutics Limited (ASX:ATX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0870
+0.0060 (7.41%)
Nov 11, 2026, 4:10 PM AEDT

Amplia Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
4512127151628
Market Cap Growth
-33.05%343.99%81.79%-9.41%-41.33%0.13%
Enterprise Value
17922312725
Last Close Price
0.090.230.070.070.080.14

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
9.3225.177.183.3613.8614.17
PB Ratio
1.133.061.291.311.041.29
P/TBV Ratio
1.423.822.084.292.092.02

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
3.5819.165.992.595.9912.57

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.010.010.000.140.140.10
Net Debt / Equity Ratio
-0.70-0.70-0.52-0.16-0.44-0.57
Net Debt / EBITDA Ratio
3.293.291.600.391.113.44
Net Debt / FCF Ratio
3.143.141.580.351.322.83
Asset Turnover
0.150.150.200.270.060.11
Quick Ratio
19.5419.547.751.933.7831.03
Current Ratio
19.7819.787.911.983.8231.18
Return on Equity (ROE)
-25.48%-25.48%-40.51%-33.05%-33.13%-22.64%
Return on Assets (ROA)
-16.29%-16.29%-22.47%-17.04%-18.20%-12.88%
Return on Capital Employed (ROCE)
-21.10%-21.10%-32.30%-39.90%-39.40%-15.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-18.86%-6.39%-24.20%-30.15%-37.85%-12.96%
FCF Yield
-19.63%-7.27%-25.36%-34.34%-32.18%-15.71%
Buyback Yield / Dilution
-52.88%-52.88%-58.35%-0.02%-33.27%-53.71%